Birdwatch Note
2023-11-30 19:31:28 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The drug in question is called Tafamidis; it was developed in 2011. Nine years before COVID-19 had spread across the world and 10 years before COVID vaccines were present, the medication was FDA-approved in 2019 and approved by the European Union in 2011. https://www.reuters.com/article/us-pfizer-approval-idUSKCN1SC0VX/ https://en.wikipedia.org/wiki/Tafamidis#:~:text=Tafamidis%20was%20approved%20in%20the,and%20in%20Japan%20in%202013.
Written by 61FCA1F734E52137C0190176751D1A44929B48843947FAD4DC01CBA2949C51F2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730251533214765155
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1730308582477066484
- noteId - 1730308582477066484
- participantId -
- noteAuthorParticipantId - 61FCA1F734E52137C0190176751D1A44929B48843947FAD4DC01CBA2949C51F2 Participant Details
- createdAtMillis - 1701372688302
- tweetId - 1730251533214765155
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The drug in question is called Tafamidis; it was developed in 2011. Nine years before COVID-19 had spread across the world and 10 years before COVID vaccines were present, the medication was FDA-approved in 2019 and approved by the European Union in 2011. https://www.reuters.com/article/us-pfizer-approval-idUSKCN1SC0VX/ https://en.wikipedia.org/wiki/Tafamidis#:~:text=Tafamidis%20was%20approved%20in%20the,and%20in%20Japan%20in%202013.
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-30 19:31:28 UTC (1701372688302) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-01 03:12:04 UTC (1701400324779) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-30 18:12:05 -0600 | Rating Details | |
| 2023-11-30 17:07:31 -0600 | Rating Details | |
| 2023-11-30 16:35:59 -0600 | Rating Details | |
| 2023-11-30 15:25:57 -0600 | Rating Details | |
| 2023-11-30 15:23:18 -0600 | Rating Details | |
| 2023-11-30 15:16:18 -0600 | Rating Details | |
| 2023-11-30 15:10:03 -0600 | Rating Details | |
| 2023-11-30 14:49:29 -0600 | Rating Details | |
| 2023-11-30 14:49:27 -0600 | Rating Details | |
| 2023-11-30 14:19:32 -0600 | Rating Details | |
| 2023-11-30 14:02:25 -0600 | Rating Details | |
| 2023-11-30 14:00:33 -0600 | Rating Details | |
| 2023-11-30 14:00:32 -0600 | Rating Details | |
| 2023-12-01 14:13:39 -0600 | Rating Details | |
| 2023-12-01 09:01:55 -0600 | Rating Details | |
| 2023-12-01 08:39:15 -0600 | Rating Details | |
| 2023-12-01 00:07:22 -0600 | Rating Details | |
| 2023-11-30 23:57:45 -0600 | Rating Details | |
| 2023-11-30 23:21:32 -0600 | Rating Details | |
| 2023-11-30 23:04:50 -0600 | Rating Details | |
| 2023-11-30 20:43:24 -0600 | Rating Details | |
| 2023-11-30 20:31:51 -0600 | Rating Details | |
| 2023-11-30 19:47:52 -0600 | Rating Details | |
| 2023-11-30 19:44:59 -0600 | Rating Details | |
| 2023-11-30 19:31:06 -0600 | Rating Details | |
| 2023-11-30 17:59:37 -0600 | Rating Details | |
| 2023-11-30 17:40:02 -0600 | Rating Details | |
| 2023-11-30 17:28:06 -0600 | Rating Details | |
| 2023-11-30 16:59:50 -0600 | Rating Details | |
| 2023-11-30 16:48:05 -0600 | Rating Details | |
| 2023-11-30 16:41:00 -0600 | Rating Details | |
| 2023-11-30 15:53:12 -0600 | Rating Details | |
| 2023-11-30 14:30:00 -0600 | Rating Details | |
| 2023-11-30 14:21:59 -0600 | Rating Details | |
| 2023-11-30 14:04:22 -0600 | Rating Details | |
| 2023-11-30 13:59:02 -0600 | Rating Details | |
| 2023-11-30 13:39:11 -0600 | Rating Details | |
| 2023-12-01 08:42:02 -0600 | Rating Details | |
| 2023-12-01 04:58:32 -0600 | Rating Details | |
| 2023-11-30 23:28:55 -0600 | Rating Details | |
| 2023-12-02 06:26:47 -0600 | Rating Details | |
| 2023-12-05 10:36:41 -0600 | Rating Details | |
| 2023-12-04 22:40:02 -0600 | Rating Details | |
| 2023-12-01 19:23:19 -0600 | Rating Details | |
| 2023-12-01 08:48:17 -0600 | Rating Details | |
| 2023-11-30 13:56:14 -0600 | Rating Details | |
| 2023-11-30 13:54:38 -0600 | Rating Details |